quinazolines has been researched along with Adrenal Cortex Cancer in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Li, H; Ma, C; Su, H; Xiong, J | 1 |
Bertele', V; Garattini, S; Gerardi, C; Joppi, R | 1 |
Adam, P; Allolio, B; Fassnacht, M; Hahner, S; Johanssen, S; Quinkler, M; Ritte, C; Ritter, C; Strasburger, C; Wortmann, S | 1 |
1 review(s) available for quinazolines and Adrenal Cortex Cancer
Article | Year |
---|---|
Letting post-marketing bridge the evidence gap: the case of orphan drugs.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Barrett Esophagus; Cladribine; Dihematoporphyrin Ether; Ductus Arteriosus, Patent; Hepatolenticular Degeneration; Humans; Ibuprofen; Leukemia, Hairy Cell; Mitotane; Orphan Drug Production; Platelet Aggregation Inhibitors; Product Surveillance, Postmarketing; Quinazolines; Thrombocythemia, Essential; Zinc Acetate | 2016 |
1 trial(s) available for quinazolines and Adrenal Cortex Cancer
Article | Year |
---|---|
Treatment of advanced adrenocortical carcinoma with erlotinib plus gemcitabine.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease Progression; Drug Administration Routes; Drug Administration Schedule; Erlotinib Hydrochloride; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Metastasis; Quinazolines; Salvage Therapy; Treatment Outcome | 2008 |
1 other study(ies) available for quinazolines and Adrenal Cortex Cancer
Article | Year |
---|---|
The underlying molecular mechanism and drugs for treatment in adrenal cortical carcinoma.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Carcinoma; Adult; Biomarkers, Tumor; Chemotherapy, Adjuvant; Computational Biology; Databases, Genetic; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; Isoquinolines; Kaplan-Meier Estimate; Male; MicroRNAs; Middle Aged; Prognosis; Protein Kinase Inhibitors; Quinazolines; RNA-Seq; RNA, Messenger; Succinimides; Sulfonamides | 2021 |